Segall Bryant & Hamill, LLC Neogenomics Inc Transaction History
Segall Bryant & Hamill, LLC
- $5.27 Billion
- Q1 2024
A detailed history of Segall Bryant & Hamill, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 1,331,981 shares of NEO stock, worth $18.3 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
1,331,981
Previous 1,357,437
1.88%
Holding current value
$18.3 Million
Previous $22 Million
4.67%
% of portfolio
0.4%
Previous 0.43%
Shares
25 transactions
Others Institutions Holding NEO
# of Institutions
279Shares Held
127MCall Options Held
1.13MPut Options Held
232K-
Black Rock Inc. New York, NY19.9MShares$272 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$195 Million0.0% of portfolio
-
Brown Advisory Inc9.67MShares$133 Million0.21% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.86MShares$94 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.28MShares$86.1 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.72B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...